PuSH - Publikationsserver des Helmholtz Zentrums München

Design of therapeutic vaccines: Hepatitis B as an example.

Microb. Biotechnol. 5, 270-282 (2012)
Verlagsversion Volltext DOI
Open Access Gold
Therapeutic vaccines are currently developed for chronic viral infections, such as human papillomavirus (HPV), human immunodeficiency virus (HIV), herpesvirus and hepatitis B (HBV) and C (HCV) virus infections. As an alternative to antiviral treatment or to support only partially effective therapy a therapeutic vaccine shall activate the patient's immune system to fight and finally control or ideally even eliminate the virus. Whereas the success of prophylactic vaccination is based on rapid neutralization of the invading pathogen by antibodies, virus control and elimination of infected cells require T cells. Therefore, induction of a multi-specific and multifunctional T-cell response against key viral antigens is a paradigm of therapeutic vaccination - besides activation of a humoral immune response to limit virus spread. In this review, we describe options to develop a therapeutic vaccine for chronic viral infections using HBV as a promising example.
Altmetric
Weitere Metriken?
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter T-CELL RESPONSES; CHRONIC HBV INFECTION; TERM-FOLLOW-UP; VIRUS-INFECTION; SURFACE-ANTIGEN; IMMUNE-RESPONSE; CORE ANTIGEN; COMBINATION THERAPY; LYMPHOCYTE RESPONSE; GERMAN GUIDELINE
ISSN (print) / ISBN 1751-7907
e-ISSN 1751-7915
Quellenangaben Band: 5, Heft: 2, Seiten: 270-282 Artikelnummer: , Supplement: ,
Verlag Wiley
Begutachtungsstatus Peer reviewed